<DOC>
	<DOCNO>NCT00967811</DOCNO>
	<brief_summary>The purpose study evaluate safety preliminary efficacy two formulation Latanoprost-PPDS subject ocular hypertension open-angle glaucoma .</brief_summary>
	<brief_title>A Study Different Formulations L-PPDS Subjects With OH OAG</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Subjects 18 year age diagnose ocular hypertension openangle glaucoma Subjects best correct visual acuity 20/100 good Subjects wear contact lenses Subjects uncontrolled medical condition Subjects require chronic topical artificial tear , lubricant , and/or require chronic ocular topical medication Subjects history chronic recurrent inflammatory eye disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>